VisiongainVisiongain is a specialist business information company focused on providing cutting edge products and services across the Pharmaceutical, Telecoms, Energy, Materials and the Defence sector, which includes management reports, conferences, online daily newsletters and bespoke consultancy. With a commitment to innovation and excellence, visiongain offers flexible solutions to meet its clients' business information needs, providing the right information at the right time to facilitate the commercial decision making process. |
View Sample from this Publisher Adobe Acrobat required |
List of reports from Visiongain
|
3G Bulletin
1/1/2000 | published by: Visiongain
... if you could get an updated report every month, with news, figures, graphs, an on-going contact directory, regulatory up-dates, a project tracker, as well as licence information and trial case-studies from the people behind the ...
|
more...
|
$1,118.40
|
|
3rd Generation Report 2001
4/15/2000 | published by: Visiongain
... it and if it's working. YOU will learn first the answers to questions such as: How will you win a license to offer 3G services and how much will it cost?; What are your COMPETITORS ...
|
more...
|
$2,078.40
|
|
The 4G Report - Sidelining the Operators
9/1/2001 | published by: Visiongain
... of the respondents, over 50% thought that a network would be ready by 2008, and more than five out of six expected one by 2010. These results will come as a warning to many 3G ...
|
more...
|
$1,598.40
|
|
The 4G Report 2005: Changing The Wireless Value Chain
5/4/2005 | published by: Visiongain
... will have a profound impact on the entire wireless landscape and the total value chain. It is never too early to understand it. 4G is happening now and there is fierce activity in R&D and ...
|
more...
|
$2,210.00
|
|
Achieving Success In The Developing Asian Pharmaceutical Sector 2007-2011
11/9/2006 | published by: Visiongain
... you succeed in them. This report tells you. Asian Developing Markets for Pharmaceuticals, 2006-2011 delivers to you unique prospects for the largest developing pharmaceutical market - Asia. This report predicts that all the leading developing ...
|
more...
|
$2,210.00
|
|
Acute Coronary Syndrome (ACS) Drug Market Prospects 2011-2021
5/6/2011 | published by: Visiongain
... and market. Our report gives you revenue forecasts to 2021 for treating acute coronary syndrome (ACS). You will find market predictions at total world, submarket, product and national levels. We aim to save you time ...
|
more...
|
$2,331.00
|
|
Ad Funded Mobile Content: Forecasts and Analysis 2008
7/24/2008 | published by: Visiongain
... cheaper and more accessible form through sponsorship of mobile advertising. As data speeds and content quality improve demand for affordable mobile content will grow among mobile consumers. Funding the content through mobile advertising allows content ...
|
more...
|
$4,663.00
|
|
The Advanced Oil & Gas Exploration Technologies Market 2011-2021
9/22/2011 | published by: Visiongain
... the market down into sub-markets and seven regional markets, with forecasts and analysis provided for each market from 2011-2021. The report also examines the major drivers and restraints influencing the market over the next decade ...
|
more...
|
$2,642.00
|
|
Advanced Wound Care: World Market Prospects 2011-2021
11/11/2011 | published by: Visiongain
... prevalence of diabetes and obesity, coupled with the aging population, which will increase the incidence of chronic wounds. The adoption of expensive but more effective wound care devices and biologics will increase in the developed ...
|
more...
|
$2,642.00
|
|
The Airborne ISR Market 2011-2021
10/3/2011 | published by: Visiongain
... parts of the world although there is also growth in others regions. While airborne ISR has seen its share of funding cuts, the sector has largely continued to enjoy financial backing from many governments as ...
|
more...
|
$2,642.00
|
|
The Airport Passenger Screening Systems Market 2011-2021
8/16/2011 | published by: Visiongain
... both within the leading U.S aviation security market and throughout the world, will ensure long-term viability for the market of airport passenger screening systems. Visiongain calculates that the global airport passenger screening systems market will ...
|
more...
|
$2,331.00
|
|
The Aluminium Market Analysis, Financials and Forecasting 2011-2016
1/6/2011 | published by: Visiongain
... report also surveys recent market trends among major companies and reveals where and why the market will experience growth, laying out the market’s strengths and weaknesses with targeted forecasts. Visiongain’s analysis has concluded that the ...
|
more...
|
$2,331.00
|
|
Alzheimer's Disease Market Analysis and Forecasts, 2007-2012, 2017 &
10/15/2007 | published by: Visiongain
... being the single most influencial factor in driving the economic growth within this sector, Visiongain believes the real market of the AD industry still remains untapped. Over the past decade the AD market has been ...
|
more...
|
$2,210.00
|
|
AMD Market Outlook to 2012
3/16/2007 | published by: Visiongain
... AMD accounts for 90% of cases and has no suitable cure. Wet AMD drug sales will soon see the first blockbuster. Novartis achieved first to market success with their Visudyne drug in 1999. However work ...
|
more...
|
$2,210.00
|
|
The Android and Apple Mobile Ecosystem 2010
7/15/2010 | published by: Visiongain
... at the reasons behind the creation of the ecosystem, including the improved User Interface of the new generation of smartphones, the introduction of new high speed mobile networks and the emergence of bundled and flat ...
|
more...
|
$2,331.00
|
|
The Annual SMS & MMS Conference 2003 - Speaker Papers
7/10/2003 | published by: Visiongain
... in Q1 2002, an increase of more than 50% over the same period of 2001. By building on the success of the SMS business model, MMS has strong potential to becoming a mass market mobile ...
|
more...
|
$642.00
|
|
The Annual Top 10 Wireless Infrastructure Vendors League
4/28/2005 | published by: Visiongain
... but with declining prices future growth is by no means assured even with new technologies coming to the fore. This report analyses where the major vendors are now, what their strategies are and where they ...
|
more...
|
$2,210.00
|
|
Anti-addiction Therapies, 2006-2011 - The Pharmaceutical Industry’s Next Viagra?
10/19/2006 | published by: Visiongain
... distress. For them their addition is a disease. According to a new report by visiongain - Anti-addiction Therapies, 2006-2011 - society is crying out for solutions. Which pharmaceutical companies are now aiming to be that ...
|
more...
|
$2,210.00
|
|
The Antibacterial Drug Market Analysis 2008-2013
3/19/2008 | published by: Visiongain
... the different drug classes used to treat these infections. However, this market is entering into a crucial period with many key products losing patent protection, facing heavy generic competition. In the light of this, including ...
|
more...
|
$2,331.00
|
|
Antibacterial Drugs: Commercial Prospects 2011-2026
1/12/2011 | published by: Visiongain
... What revenues will the world antibacterial drug market yield from 2011 to 2026? What will be the revenue prospects for leading antibacterial products? What will be the sales trends for leading national markets, developed and ...
|
more...
|
$2,331.00
|
|
Antibacterial Drugs: World Market Prospects 2012-2022
11/28/2011 | published by: Visiongain
... 2022. Our report gives you business research, analysis and opinion for the treatment of bacterial infections. How will 20 leading products - including Levaquin, Zyvox, Avelox, Augmentin, Zosyn, Merrem, Cubicin, Primaxin and Cravit - perform ...
|
more...
|
$2,642.00
|
|
Anti-Infectives 2002
9/1/2002 | published by: Visiongain
... make sure you order this report today The anti-infectives market is poised to experience considerable growth in the next few years, with a forecast market value that is expected to double in size to more ...
|
more...
|
$3,518.00
|
|
The Anti-Migraine Market 2007-2022
11/13/2007 | published by: Visiongain
... of migraine is significant. Furthermore, the people most susceptible to migraine are those within their most productive years (22-55), causing both personal and professional disruptions and a significant burden on healthcare services. This in-depth management ...
|
more...
|
$2,210.00
|
|
The Antipsychotics Market Insight & Analysis 2008
2/19/2008 | published by: Visiongain
... you. This in-depth market analysis examines prospects for antipsychotic drugs right through to 2012, including sales forecasts for leading products. The antipsychotics market will face decreasing growth throughout the forecast period, due to the patent ...
|
more...
|
$2,331.00
|
|
Antithrombotic/Anticoagulant Drugs: World Market 2012-2022
1/10/2012 | published by: Visiongain
... at world market, therapeutic class, product and national levels to 2022. How will products - Plavix, Lovenox, Pletal, Fragmin, Asasantin, Arixtra, Aspirin Cardio, Effient, Pradaxa, Brilinta and others - perform? Our report gives you business ...
|
more...
|
$2,642.00
|

